McCarthy Tétrault is well-versed in advising on life sciences and biotech issues, advising on a mix of corporate, IP and commercial matters. The team handling major transactions in the life sciences sector, advising private and public biotech, chemical and pharmaceutical companies. The Montréal and Québec City practice is led by Philippe Leclerc, who represents life sciences clients in commercial, corporate and securities law issues. He excels in IPOs, acquisitions, takeovers, public and private financing. David Frost leads the Vancouver group and advises international and domestic life sciences companies on corporate governance, financings and M&As. Lisa Melanson sits in Toronto and is the go-to for regulatory compliance issues and IP matters. She focuses on drug regulation issues and cross-border regulatory advise involving the US and Canada.
Legal 500 Editorial commentary

Key clients

  • Medicenna Therapeutics
  • Aptose Biosciences
  • Novartis acquisition of Chinook Therapeutics
  • Tilt
  • Jupiter Research
  • Cantor Fitzgerald / Zymeworks
  • Bloom Burton & Co.
  • Kedrion/Prometic
  • ModernaTX
  • MinafinDelmar
  • Otsuka Pharmaceutical
  • Quest Diagnostics

Lawyers

Leading partners

The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.

Practice head

Philippe Leclerc; David Frost

Other key lawyers

Lisa Melanson